Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBIT Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBIT Margin for 2 consecutive years, with 5773.71% as the latest value for Q1 2024.

  • On a quarterly basis, EBIT Margin changed N/A to 5773.71% in Q1 2024 year-over-year; TTM through Dec 2024 was 26806.37%, a N/A change, with the full-year FY2024 number at 26805.58%, down 2671242.0% from a year prior.
  • EBIT Margin was 5773.71% for Q1 2024 at Artiva Biotherapeutics, down from 672.09% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 672.09% in Q4 2023 to a low of 5773.71% in Q1 2024.